Target intelligence / Profile preview

Androctonus australis hector alpha-toxin (Aah alpha-toxin) (Aah alpha-toxin)

Target
Aah alpha-toxin
Molecular classification
Scorpion toxin, Voltage-gated sodium channel modulator, Neurotoxin, Other
01

Overview

Androctonus australis hector (Aah) alpha-toxins are a group of highly potent neurotoxic peptides found in the venom of the North African scorpion. These toxins, particularly the well-studied Aah II, are the primary drivers of toxicity in humans following envenomation (UniProt: P01490). They function by binding with high affinity to neurotoxin receptor site 3 on voltage-gated sodium (Nav) channels, primarily in the nervous and muscular systems (Cestèle & Catterall, 2000). This binding slows the inactivation of the sodium channel, leading to prolonged depolarization and repetitive firing of action potentials, which manifests clinically as an autonomic storm involving massive release of catecholamines and acetylcholine (Martin-Eauclaire et al., 2019). Because of their lethal potency, these toxins are the primary targets for the development of therapeutic antivenoms and next-generation neutralizing agents like nanobodies. Understanding their structure-function relationship is critical for designing effective treatments against scorpionism in endemic regions.

Other names
Aah IIAah IAlpha-mammal toxinScorpion toxin IIButhidae alpha-neurotoxinSite 3 toxin
02

Mechanism of action

The toxins bind to neurotoxin receptor site 3 on the extracellular loops of voltage-gated sodium channels (Nav), specifically hindering the movement of the S4 segment in domain IV. This action slows the inactivation process of the channel, leading to prolonged sodium influx and persistent depolarization of excitable cells.

03

Biological functions

Signal transductionInhibition of voltage-gated sodium channel inactivationInduction of repetitive action potentialsOther
04

Disease associations

Scorpion envenomationNeurotoxicityAutonomic stormOther
05

Safety considerations

Extreme potency (LD50 in the microgram range)Rapid systemic distribution and onset of life-threatening symptomsRisk of serum sickness or anaphylaxis from heterologous antivenomsPotential for cardiac and respiratory failure
06

Interacting drugs

Scorpion antivenom

2 more in the full profile.

07

Biomarkers

Serum toxin concentration (ELISA)Blood glucose levels (hyperglycemia is a common clinical marker)Creatine kinase levels (marker of muscle damage)Leukocyte count (leukocytosis is common in severe envenomation)

Beyond the preview

Go deeper on Androctonus australis hector alpha-toxin (Aah alpha-toxin) (Aah alpha-toxin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Androctonus australis hector alpha-toxin (Aah alpha-toxin) (Aah alpha-toxin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call